Clinical Trials Directory

Trials / Terminated

TerminatedNCT06346704

Prospective Longitudinal Monocentric Study to Evaluate the Syde® Digital Endpoint in Patients With Multiple Sclerosis

Prospective Longitudinal Monocentric Study to Evaluate the Syde® Digital Endpoint in Patients With Multiple Sclerosis (NHS-MS-EGYPT)

Status
Terminated
Phase
Study type
Observational
Enrollment
86 (actual)
Sponsor
SYSNAV · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers

Summary

The study aims to assess the validity of real-world activity monitoring by the Syde® wearable device in subjects with multiple slclerosis. The Syde® collected data will be compared to on-site conventional clinical endpoints for MS pathology (EDSS, FSS and T25FWT). Subjects with multiple sclerosis will be assessed every 6 months for 2 years.

Conditions

Interventions

TypeNameDescription
OTHERDigital HealthTechnologySubject will wear the Syde® for 1 month every 6 months

Timeline

Start date
2024-04-25
Primary completion
2025-04-25
Completion
2025-04-25
First posted
2024-04-04
Last updated
2025-12-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06346704. Inclusion in this directory is not an endorsement.